Search
for
Sort by
Research 541–570 of 1000+
- Genetic basis of polycystic ovary syndrome
- Rabson-Mendenhall syndrome: two case reports and a brief review of the literature
- DERMATOLOGIC DISEASES AND PROBLEMS OF WOMEN THROUGHOUT THE LIFE CYCLE
- Applications of Nanostructured Lipid Carriers: Recent Advancements and Patent Review
- Considerations in genetic counseling of transgender patients: Cultural competencies and altered disease risk profiles
- Managing polycystic ovary syndrome in primary care
- Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature
- Congenital adrenal hyperplasia
- Skin diseases in consequence of endocrine alterations
- Cardiovascular Risk Associated With Gender Affirming Hormone Therapy in Transgender Population
- Current aspects of polycystic ovary syndrome: A literature review
- Association of AR rs6152G/A gene polymorphism with susceptibility to polycystic ovary syndrome in Chinese women
- Raising threshold for diagnosis of polycystic ovary syndrome excludes population of patients with metabolic risk
- Exploring the Multifaceted Impact of Acne on Quality of Life and Well-Being
- Topical and nutricosmetic products for healthy hair and dermal antiaging using “dual‐acting” (2 for 1) plant‐based peptides, hormones, and cannabinoids
- Circulating sex hormone binding globulin levels are modified with intensive lifestyle intervention, but their changes did not independently predict diabetes risk in the Diabetes Prevention Program
- Metabolic dysfunction in obese Hispanic women with polycystic ovary syndrome
- Treatment of insulin resistance with tirzepatide leading to improvement of hair loss
- The good, the bad, and the ugly facets of insulin resistance
- Polycystic ovary syndrome
- Association of estrogen receptor gene variants (ESR1 and ESR2) with polycystic ovary syndrome in Tunisia
- Epicardial Fat Thickness in Children with Classic Congenital Adrenal Hyperplasia
- Women’s Health Considerations for Lipid Management
- A patient with combined polycystic ovary syndrome and autoimmune polyglandular syndrome type 2
- Focal and Generalized Alopecia
- Testosterone Treatment in Women – An Overview
- Clinical manifestations of polycystic ovary syndrome
- Histological and Gene Expression Analysis of the Effects of Menopause Status and Hormone Therapy on the Vaginal Introitus and Labia Majora
- Transgender and Migraine
- The role of aquaporins in polycystic ovary syndrome – A way towards a novel drug target in PCOS